Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026)
Nyxoah (NYXH) recorded quarterly Cash from Investing Activities of $5.4 million in Q1 2026, up 163.64% quarter-over-quarter from -$8.5 million in Q4 2025, and down 36.97% on a YoY basis from $8.6 million in Q1 2025.
Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Nyxoah's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 36.97% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $28.4 million (up 226.24% YoY), while the FY2025 annual figure was $33.0 million, up 289.05% from the prior year.
- Cash from Investing Activities was $5.4 million for Q1 2026 at Nyxoah, up from -$8.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $53.4 million in Q1 2022 to a low of -$84.3 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$3.8 million across 5 years, with a median of $5.9 million in 2024.
- Biggest YoY gain for Cash from Investing Activities was 2593.7% in 2022; the steepest drop was 1050.09% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$59.5 million in 2022, then jumped by 120.51% to $12.2 million in 2023, then tumbled by 157.62% to -$7.0 million in 2024, then dropped by 20.49% to -$8.5 million in 2025, then soared by 163.64% to $5.4 million in 2026.
- The last three Cash from Investing Activities figures came in at $5.4 million (Q1 2026), -$8.5 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 5.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.39 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Mar 31, 2023 | 12.20 Mn |
| Mar 31, 2023 | 12.20 Mn |